Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'ARCHIMBAUD E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 130 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. de Witte, T; Suciu, S; Verhoef, G; Labar, B; Archimbaud, E; Aul, C; Selleslag, D; Ferrant, A; Wijermans, P; Mandelli, F; Amadori, S; Jehn, U; Muus, P; Boogaerts, M; Zittoun, R; Gratwohl, A; Zwierzina, H; Hagemeijer, A; Willemze, R
      Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS

      BLOOD
    2. de Witte, T; Suciu, S; Verhoef, G; Labar, B; Archimbaud, E; Aul, C; Selleslag, D; Ferrant, A; Wijermans, P; Mandelli, F; Amadori, S; Jehn, U; Muus, P; Demuynck, H; Dardenne, M; Zittoun, R; Willemze, R; Gratwohl, A; Apperley, J
      Intensive chemotherapy followed by stem cell transplantation for the treatment of myelodysplastic syndromes

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    3. Thiebaut, A; Thomas, X; Belhabri, A; Anglaret, B; Archimbaud, E
      Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis

      ANNALS OF HEMATOLOGY
    4. Coronel, B; Levron, JC; Dorez, D; Van Devenne, A; Archimbaud, E; Mercatello, A
      Itraconazole lung concentrations in haematological patients

      MYCOSES
    5. Thomas, X; Troncy, J; Belhabri, A; Thiebaut, A; Bouheddou, N; Michallet, M; Fleurette, J; Pivot, C; Fiere, D; Archimbaud, E
      A double-blind randomized study evaluating the vancomycin-pefloxacin combination as a gastrointestinal tract decontaminant for the prevention of infections in patients with chemotherapy-induced neutropenia

      PRESSE MEDICALE
    6. Michallet, M; Philip, T; Philip, I; Godinot, H; Sebban, C; Salles, G; Thiebaut, A; Biron, P; Lopez, F; Mazars, P; Roubi, N; Leemhuis, T; Hanania, E; Reading, C; Fine, G; Atkinson, K; Juttner, C; Coiffier, B; Fiere, D; Archimbaud, E
      Transplantation with selected autologous peripheral blood CD34(+)Thy1(+) hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution

      EXPERIMENTAL HEMATOLOGY
    7. Michallet, M; Thomas, X; Vernant, JP; Kuentz, M; Socie, G; Esperou-Bourdeau, H; Milpied, N; Blaise, D; Rio, B; Reiffers, J; Jouet, JP; Cahn, JY; Bourhis, JH; Lioure, B; Leporrier, M; Sotto, JJ; Souillet, G; Sutton, L; Bordigoni, P; Dreyfus, F; Tilly, H; Gratecos, N; Attal, M; Leprise, PY; Demeocq, F; Michel, G; Buzyn, A; Delmas-Marsalet, B; Bernaudin, F; Ifrah, N; Sadoun, A; Guyotat, D; Cavazzana-Cavo, M; Caillot, D; De Revel, T; Vannier, JP; Baruchel, A; Fegueux, N; Tanguy, ML; Thiebaut, A; Belhabri, A; Archimbaud, E
      Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)

      BONE MARROW TRANSPLANTATION
    8. Thomas, X; Cambier, N; Taksin, AL; Reman, O; Vekhoff, A; Pautas, C; Leblond, V; Soler-Michel, P; Ecstein-Fraisse, E; Archimbaud, E
      Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia

      LEUKEMIA RESEARCH
    9. Thomas, X; Teillon, MH; Belhabri, A; Rimokh, R; Fiere, D; Magaud, JP; Archimbaud, E
      Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission

      HEMATOLOGY AND CELL THERAPY
    10. Belhabri, A; Thomas, X; Troncy, J; Assouline, D; Michallet, M; Wattel, E; Tigaud, JD; Blanc, M; Fiere, D; Archimbaud, E
      Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study

      LEUKEMIA & LYMPHOMA
    11. Thomas, X; Fenaux, P; Dombret, H; Delair, S; Dreyfus, F; Tilly, H; Vekhoff, A; Cony-Makhoul, P; Leblond, V; Troussard, X; Cordonnier, C; de Revel, T; Simon, M; Nicolini, F; Stoppa, AM; Janvier, M; Bordessoule, D; Rousselot, P; Ffrench, M; Marie, JP; Archimbaud, E
      Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

      LEUKEMIA
    12. Archimbaud, E; Jehn, U; Thomas, X; De Cataldo, F; Fillet, G; Belhabri, A; Peaud, PY; Martin, C; Amadori, S; Willemze, R
      Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction consolidation therapy, followedby a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia

      LEUKEMIA
    13. Michallet, M; Perrin, MC; Belhabri, A; Molina, L; Nicolini, F; Tigaud, JD; Sotto, JJ; Guyotat, D; Fiere, D; Archimbaud, E
      Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    14. Fenaux, P; Chastang, C; Chevret, S; Sanz, M; Dombret, H; Archimbaud, E; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Maloisel, F; Castaigne, S; Preudhomme, C; Degos, L
      A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia

      BLOOD
    15. Archimbaud, E; Ottmann, OG; Yin, JAL; Lechner, K; Dombret, H; Sanz, MA; Heil, G; Fenaux, P; Brugger, W; Barge, A; O'Brien-Ewen, C; Matcham, J; Hoelzer, D
      A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia

      BLOOD
    16. THOMAS X; THIEBAUT A; OLTEANU N; DANAILA C; CHARRIN C; ARCHIMBAUD E; FIERE D
      PHILADELPHIA-CHROMOSOME-POSITIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA -CHARACTERISTICS, PROGNOSTIC FACTORS AND TREATMENT OUTCOME

      HEMATOLOGY AND CELL THERAPY
    17. THOMAS X; ANGLARET B; ADELEINE P; MARITAZ O; BAILLY M; FIERE D; ARCHIMBAUD E
      INFLUENCE OF MALIGNANT-CELL CLONOGENIC CAPACITIES AND POSITION ALONG THE MATURATION PATHWAY ON THEIR SUSCEPTIBILITY TO LYMPHOKINE-ACTIVATEDKILLER-CELL CYTOTOXICITY

      Leukemia & lymphoma
    18. Thomas, X; Anglaret, B; Magaud, JP; Epstein, J; Archimbaud, E
      Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma

      LEUKEMIA & LYMPHOMA
    19. Maraninchi, D; Vey, N; Viens, P; Stoppa, AM; Archimbaud, E; Attal, M; Baume, D; Bouabdallah, R; Demeoq, F; Fleury, J; Michallet, M; Olive, D; Reiffers, J; Sainty, D; Tabilio, A; Tiberghien, P; Brandely, M; Hercend, T; Blaise, D
      A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia

      LEUKEMIA & LYMPHOMA
    20. PINTO A; ZULIAN GB; ARCHIMBAUD E
      ACUTE MYELOGENOUS LEUKEMIA

      Critical reviews in oncology/hematology
    21. THOMAS X; FIERE D; ARCHIMBAUD E
      INFLUENCE OF INCREASED BODY-MASS INDEX ON DRUG TOXICITY IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    22. ARCHIMBAUD E; CHARRIN C; MAGAUD JP; CAMPOS L; THOMAS X; FIERE D; RIMOKH R
      CLINICAL AND BIOLOGICAL CHARACTERISTICS OF ADULT DE-NOVO AND SECONDARY ACUTE MYELOID-LEUKEMIA WITH BALANCED 11Q23 CHROMOSOMAL ANOMALY OR MLL GENE REARRANGEMENT COMPARED TO CASES WITH UNBALANCED 11Q23 ANOMALY -CONFIRMATION OF THE EXISTENCE OF DIFFERENT ENTITIES WITH 11Q23 BREAKPOINT

      Leukemia
    23. LOWENBERG B; SUCIU S; ARCHIMBAUD E; HAAK H; STRYCKMANS P; DECATALDO R; DEKKER AW; BERNEMAN ZN; THYSS A; VANDERLELIE J; SONNEVELD P; VISANI G; FILLET G; HAYAT M; HAGEMEIJER A; SOLBU G; ZITTOUN R
      MITOXANTRONE VERSUS DAUNORUBICIN IN INDUCTION-CONSOLIDATION CHEMOTHERAPY - THE VALUE OF LOW-DOSE CYTARABINE FOR MAINTENANCE OF REMISSION, AND AN ASSESSMENT OF PROGNOSTIC FACTORS IN ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - FINAL REPORT OF THE LEUKEMIA COOPERATIVE GROUP OF THE ANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER AND THE DUTCH-BELGIAN HEMATOONCOLOGY COOPERATIVE HOVON GROUP RANDOMIZED PHASE-III STUDY AML-9

      Journal of clinical oncology
    24. GUARDIOLA P; SOCIE G; PASQUINI R; DOKAL I; ORTEGA JJ; VANWEELSIPMAN M; MARSH J; LOCATELLI F; SOUILLET G; CAHN JY; LJUNGMAN P; MINIERO R; SHAW J; VERMYLEN C; ARCHIMBAUD E; BEKASSY AN; KRIVAN G; DIBARTOLOMEO P; BACIGALUPO A; GLUCKMAN E
      ALLOGENEIC STEM-CELL TRANSPLANTATION FOR FANCONI-ANEMIA

      Bone marrow transplantation
    25. DEWITTE T; VANBIEZEN A; HERMANS J; SUCIU S; DARDENNE M; LABAR B; ARCHIMBAUD E; AUL C; SELLESLAG D; FERRANT A; MELONI G; MAURI SB; CARELLA A; LAPORTE J; DEMUYNCK H; NIEDERWIESER D; GRATWOHL A; APPERLEY J
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SECUNDARY ACUTE MYELOID-LEUKEMIA

      Bone marrow transplantation
    26. KEATING S; SUCIU S; MANDELLI F; DEWITTE T; ZITTOUN R; ARCHIMBAUD E; RESEGOTTI L; MELONI G; FAZI P; DARDENNE M; WILLEMZE R
      RESULTS OF POSTCONSOLIDATION TREATMENT FOR PATIENTS LESS-THAN 51 YEARS OF AGE WITH AML IN FIRST CR IN THE AML 10 STUDY OF THE LEUKEMIA COOPERATIVE GROUP OF THE EORTC AND GIMEMA

      Bone marrow transplantation
    27. ARCHIMBAUD E; PHILIP I; COIFFIER B; MICHALLET M; SALLES G; SEBBAN C; ROUBI N; LOPEZ F; BESSUEILLE L; MAZARS P; GERARD C; HANANIA E; RAMANATHAN R; READING C; JUTTNER C; ATKINSON K; PHILIP T
      SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( THY)

      Bone marrow transplantation
    28. THIEBAUT A; MICHALLET M; GEBUHRER L; LASNE Y; CHARRIN C; MOLLET I; BELHABRI A; ARCHIMBAUD E
      DONOR LYMPHOCYTE INFUSIONS (DLI) FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - HEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESULTS

      Bone marrow transplantation
    29. BELHABRI A; MICHALLET M; THIEBAUT A; PHILIP I; CHARRIN C; FIERE D; ARCHIMBAUD E
      AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOCYTIC-LEUKEMIA (CML) WITH PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY G-CSF (FILGRASTIM) AND INTERFERON-ALPHA (IFN)

      Bone marrow transplantation
    30. DEWITTE T; VANBIEZEN A; HERMANS J; SUCIU S; DARDENNE M; LABAR B; ARCHIMBAUD E; AUL C; SELLESLAG D; FERRANT A; MELONI G; MAURI SB; CARELLA A; LAPORTE J; DEMUYNCK H; NIEDERWIESER D; GRATWOHL A; APPERLEY J
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SECUNDARY ACUTE MYELOID-LEUKEMIA, ON BEHALF OF THE MDS STUDY-GROUP OF THE EBMT CLWP AND THE EORTC-LCG

      Bone marrow transplantation
    31. THOMAS X; ANGLARET B; BAILLY M; MARITAZ O; MAGAUD JP; ARCHIMBAUD E
      DIFFERENTIAL ADHESIVENESS BETWEEN BLOOD AND MARROW LEUKEMIC-CELLS HAVING SIMILAR PATTERN OF VLA ADHESION MOLECULE EXPRESSION

      Leukemia research
    32. THOMAS X; ANGLARET B; CAMPOS L; THIEBAUT A; SABIDO O; BAILLY M; ARCHIMBAUD E
      EXPRESSION OF BETA-1-INTEGRINS AND PSEUDO-IMMUNOGLOBULINS ON ACUTE PROMYELOCYTIC LEUKEMIA-CELLS AND ITS MODIFICATIONS DURING IN-VITRO DIFFERENTIATION

      Leukemia research
    33. Archimbaud, E; Thomas, X
      Thrombopoietic factors potentially useful in the treatment of acute leukemia

      LEUKEMIA RESEARCH
    34. THOMAS X; CORDONNIER C; DOMBRET H; FEGUEUX N; MALOISEL F; VEKHOFF A; REMAN O; VILQUE JP; GRATECOS N; DEREVEL T; COASIN T; BUZYN A; CAHN JY; GUERCI A; CHOMIENNE C; ARCHIMBAUD E; DEGOS L; FENAUX P
      ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY TIMED SEQUENTIAL CHEMOTHERAPY (EMA) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA (APL)

      British Journal of Haematology
    35. ARCHIMBAUD E; FENAUX P; DOMBRET H; DREYFUS F; TILLY H; CONYMAKHOUL P; LEBLOND V; TROUSSARD X; DELAIR S; FFRENCH M; MARIE JP
      GM-CSF TO INCREASE EFFICACY OF SEQUENTIAL CHEMOTHERAPY IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL (EMA91)

      British Journal of Haematology
    36. TAKSIN AL; THOMAS X; CASTAIGNE S; ROUSSELOT P; DEGOS L; ARCHIMBAUD E; DOMBRET H
      LIMITS FOR INTENSIFYING INDUCTION THERAPY IN YOUNGER PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA (AML)

      British Journal of Haematology
    37. DEWITTE T; SUCIU S; VERHOEF G; LABAR B; ARCHIMBAUD E; AUL C; SELLESLAG D; FERRANT A; WIJERMANS P; MANDELLI F; AMADORI S; JEHN U; MUUS P; DEMUYNCK H; DARDENNE M; ZITTOUN R; WILLEMZE R; GRATWOHL A; APPERLEY J
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH POOR-RISK MDS AND SECUNDARY AML (SAML)

      British Journal of Haematology
    38. THIEBAUT A; MICHALLET M; GEBUHRER L; LASNE Y; CHARRIN C; MOLLET I; BELHABRI A; ARCHIMBAUD E
      DONOR LYMPHOCYTE INFUSIONS (DLI) FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - HEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESULTS

      British Journal of Haematology
    39. ARCHIMBAUD E
      IMMUNE RECONSTITUTION FOLLOWING TRANSPLANTATION OF SELECTED HEMATOPOIETIC STEM-CELLS

      HEMATOLOGY AND CELL THERAPY
    40. THOMAS X; ARCHIMBAUD E
      MITOXANTRONE IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A REVIEW

      HEMATOLOGY AND CELL THERAPY
    41. THOMAS X; HIRSCHAUER C; TRONCY J; ASSOULINE D; JOLY MO; FIERE D; ARCHIMBAUD E
      SERUM INTERLEUKIN-6 LEVELS IN ADULT ACUTE MYELOGENOUS LEUKEMIA - RELATIONSHIP WITH DISEASE CHARACTERISTICS AND OUTCOME

      Leukemia & lymphoma
    42. HOELZER D; HOFMANN WK; OTTMANN OG; DOMBRET H; HERRMANN F; GANSER A; KANZ L; FENAUX P; YIN JAL; LECHNER K; SANZ MA; ARCHIMBAUD E
      EFFECT OF PEG-RHU MGDF IN THE INDUCTION TREATMENT OF ACUTE MYELOID-LEUKEMIA

      European journal of cancer
    43. THOMAS X; ANGLARET B; THIEBAUT A; BELHABRI A; TREILLERITOUET D; FIERE D; ARCHIMBAUD E
      IMPROVEMENT OF PROGNOSIS IN REFRACTORY AND RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA OVER RECENT YEARS - THE ROLE OF ALL-TRANS-RETINOIC ACID THERAPY

      Annals of hematology
    44. HAYETTE S; THOMAS X; BERTRAND Y; TIGAUD I; CALLANAN M; THIEBAUT A; CHARRIN C; ARCHIMBAUD E; MAGAUD JP; RIMOKH R
      MOLECULAR ANALYSIS OF CYCLIN-DEPENDENT KINASE INHIBITORS IN HUMAN LEUKEMIAS

      Leukemia
    45. WILLEMZE R; SUCIU S; ARCHIMBAUD E; MUUS P; STRYCKMANS P; LOUWAGIE EA; BERNEMAN Z; TJEAN M; WIJERMANS P; DOHNER H; JEHN U; LABAR B; JAKSIC B; DARDENNE M; ZITTOUN R
      A RANDOMIZED PHASE-II STUDY ON THE EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE COMBINED WITH EITHER AMSACRINE OR IDARUBICIN IN PATIENTS WITH RELAPSEDACUTE-LEUKEMIA - AN EORTC LEUKEMIA COOPERATIVE GROUP PHASE-II STUDY-(06893)

      Leukemia
    46. THOMAS X; ANGLARET B; MARITAZ O; BAILLY M; MAGAUD JP; ARCHIMBAUD E
      FUNCTIONAL OVERLAP BETWEEN CYTOKINES AND ADHESION MOLECULES FOR THE PARACRINE IL-6 PRODUCTION IN MYELOMA

      Experimental hematology
    47. THOMAS X; RIMOKH R; TEILLON MH; BELHABRI A; MAGAUD JP; ARCHIMBAUD E
      HYPERMETHYLATION OF THE CALCITONIN-GENE IN ADULT ACUTE-LEUKEMIA AT DIAGNOSIS AND DURING CR

      Experimental hematology
    48. CHARRIN C; BELHABRI A; TREILLERITOUET D; THEUIL G; MAGAUD JP; ARCHIMBAUD E
      STRUCTURAL REARRANGEMENTS OR CHROMOSOME-3 IN ACUTE MYELOID LEUKEMIAS (AML)

      Experimental hematology
    49. WAHBI K; HAYETTE S; CALLANAN M; GADOUX M; CHARRIN C; ARCHIMBAUD E; MAGAUD JP; RIMOKH R
      INVOLVEMENT OF A HUMAN ENDOGENOUS RETROVIRAL SEQUENCE (THE-7) IN A T(7-14)(Q21-Q32) CHROMOSOMAL TRANSLOCATION ASSOCIATED TO A B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA

      Experimental hematology
    50. MICHALLET M; JAVAUX F; GEBUHRER L; BELHABRI A; BOUHEDDOU N; CHARRIN C; LASNE Y; FIERE D; ARCHIMBAUD E
      COMPARISON BETWEEN CYTOGENETIC AND MOLECULAR STUDIES (CHIMERISM AND MINIMAL RESIDUAL DISEASE) FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - INTEREST FOR STRATEGY AFTER RELAPSE POSTTRANSPLANT

      Experimental hematology
    51. ARCHIMBAUD E; MICHALLET M; PHILIP L; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      G-CSF (FILGRASTIM) ADMINISTERED IN ADDITION TO INTERFERON-ALPHA (IF) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA (CML)

      Experimental hematology
    52. HAYETTE S; GADOUX M; MARTEL S; TIGAUD I; ARCHIMBAUD E; MAGAUD JP; RIMOKH R
      A NEW FOLLISTATIN-RELATED GENE, FLRG, IS AFFECTED BY CHROMOSOMAL REARRANGEMENT IN MALIGNANT BLOOD DISORDERS

      Experimental hematology
    53. CHARRIN C; BELHABRI A; TREILLERITOUET D; THEUIL G; MAGAUD JP; ARCHIMBAUD E
      STRUCTURAL REARRANGEMENTS OF CHROMOSOME-3 IN ACUTE MYELOID LEUKEMIAS (AML)

      Cytogenetics and cell genetics
    54. JOURDAN E; MARANINCHI D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; MOLINA L; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNEAU C; TILLY H; VILMER E; BARDOU VJ; BLAISE D
      EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA

      Bone marrow transplantation
    55. ARCHIMBAUD E; MICHALLET M; PHILIP I; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      GRANULOCYTE-COLONY-STIMULATING FACTOR GIVEN IN ADDITION TO INTERFERON-ALPHA TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA

      British Journal of Haematology
    56. LOWENBERG B; SUCIU S; ARCHIMBAUD E; OSSENKOPPELE G; VERHOEF GEG; VELLENGA E; WIJERMANS P; BERNEMAN Z; DEKKER AW; STRYCKMANS P; SCHOUTEN H; JEHN U; MUUS P; SONNEVELD P; DARDENNE M; ZITTOUN R
      USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DURING AND AFTER REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS AGED 61 YEARS AND OLDER WITH ACUTE MYELOID-LEUKEMIA (AML) - FINAL REPORT OF AML-11, A PHASE-III RANDOMIZED STUDY OF THE LEUKEMIA COOPERATIVE GROUP OFANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC-LCG) AND THE DUTCH BELGIAN HEMATOONCOLOGY COOPERATIVE GROUP (HOVON)

      Blood
    57. THOMAS X; THIEBAUT A; OLTEANU N; CHARRIN C; ARCHIMBAUD E; FIERE D
      PHILADELPHIA-CHROMOSOME-POSITIVE (PH-LEUKEMIA (ALL) - CLINICAL AND CYTOGENETIC CHARACTERISTICS, PROGNOSTIC FACTORS AND TREATMENT OUTCOME() ADULT ACUTE LYMPHOBLASTIC)

      Blood
    58. THIEBAUT A; ANGLARET B; THOMAS X; LE QH; CHABERT C; BELHABRI A; FIERE D; ARCHIMBAUD E
      IMPACT OF PREINDUCTION THERAPY LEUKAPHERESIS ON TREATMENT OUTCOME IN ADULT ACUTE MYELOGENOUS LEUKEMIA (AML) PRESENTING WITH HYPERLEUKOCYTOSIS

      Blood
    59. MICHALLET M; BELHABRI A; ARCHIMBAUD E; TANGUY ML; VERNANT JP; RAFFOUX C; MARRY E; JOUET JP; GOLMARD JL
      STUDY OF 600 PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) ENROLLED ONFRANCE-GREFFE-DE-MOELLE (FGM) REGISTRY WITH AN INTENTION TO TRANSPLANT FROM UNRELATED DONORS

      Blood
    60. MARIT G; FACON T; JOUET JP; KUENTZ M; VERNANT JP; ARCHIMBAUD E; MICHALLET M; HAROUSSEAU JL; MILPIED N; MOLINA L; SOTTO JJ; GUILHOT B; BLAISE D; ATTAL M; FABERES C; TANGUY ML; REIFFERS J
      ALLOGENEIC STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A REPORT OF THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)

      Blood
    61. KEATING S; SUCIU S; MANDELLI F; DEWITTE T; WILLEMZE R; ARCHIMBAUD E; HAYAT M; ROTOLI B; LABAR B; RESEGOTTI L; FAZI P; DARDENNE M; ZITTOUN R
      AUTOLOGOUS BMT OR PSCT FOR PATIENTS WITH AML IN FIRST CR - A PRELIMINARY-ANALYSIS OF THE AML-10 STUDY OF THE LEUKEMIA COOPERATIVE GROUP (LCG) OF THE EORTC AND GIMEMA

      Blood
    62. FENAUX P; CHASTANG C; CASTAIGNE S; ARCHIMBAUD E; LINK H; FEY M; GUERCI A; FEGUEUX N; BOWEN D; LOWENBERG B; GARDIN C; MALOISEL F; STAMATOULAS A; STOPPA AM; SADOUN A; JACKY E; GANSER A; AUZANNEAU G; CHOMIENNE C; DEGOS L
      LONG-TERM FOLLOW-UP CONFIRMS THE SUPERIORITY OF ATRA COMBINED WITH CHEMOTHERAPY (CT) OVER CT ALONE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - (APL-91 TRIAL)

      Blood
    63. ARCHIMBAUD E; PHILIP I; COIFFIER B; MICHALLET M; SALLES G; SEBBAN C; ROUBI N; LOPEZ F; BESSUEILLE L; MAZARS P; GERARD C; HANANIA S; RAMANATHAN R; READING C; JUTTNER C; ATKINSON K; PHILIP T
      SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA - A EUROPEAN STUDY( THY)

      Blood
    64. ARCHIMBAUD E; FENAUX P; DOMBRET H; DREYFUS F; TILLY H; CONYMAKHOUL P; LEBLOND V; TROUSSARD X; DELAIR S; FFRENCH M; MARIE JP
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) TO INCREASEEFFICACY OF INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH MITOXANTRONE(M), ETOPOSIDE(E) AND CYTARABINE(A) IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED TRIAL

      Blood
    65. MICHALLET M; TANGUY ML; BELHABRI A; ARCHIMBAUD E; JOUET JP; FOULON N; MICHALLET AS; VERNANT JP
      RETRANSPLANTATION FOR RELAPSE AFTER FIRST ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT OF 167 CASES FOR THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)

      Blood
    66. DEWITTE T; SUCIU S; VERHOEF G; LABAR B; ARCHIMBAUD E; AUL C; SELLESLAG D; FERRANT A; WIJERMANS P; MANDELLI F; AMADORI S; JEHN U; MUUS P; DEMUYNCK H; DARDENNE M; ZITTOUN R; WILLEMZE R; GRATWOHL A; APPERLEY J
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR PATIENTS WITH POOR-RISK MDS AND SECONDARY AML (SAML) - A JOINT STUDY OF THE EORTC, EBMT, SAKK AND GIMEMA LEUKEMIA GROUPS

      Blood
    67. MACINTYRE E; BOURQUELOT P; LEBOEUF D; RIMOKH R; ARCHIMBAUD E; SMETSERS T; ZITTOUN R
      MLL CLEAVAGE OCCURS IN APPROXIMATELY 5-PERCENT OF DE-NOVO ACUTE MYELOID-LEUKEMIA, INCLUDING IN PATIENTS ANALYZED BEFORE TREATMENT INDUCTION

      Blood
    68. ARCHIMBAUD E; LEBLOND V; FENAUX P; DOMBRET H; CORDONNIER C; DREYFUS F; CONYMAKHOUL P; TILLY H; TROUSSARD X; AUZANNEAU G; THOMAS X; FFRENCH M; MARIE JP
      TIMED SEQUENTIAL CHEMOTHERAPY FOR ADVANCED ACUTE MYELOID-LEUKEMIA

      HEMATOLOGY AND CELL THERAPY
    69. THOMAS X; ANGLARET B; TREILLERITOUET D; BASTION Y; FIERE D; ARCHIMBAUD E
      OCCURRENCE OF T-CELL LYMPHOMA IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA

      Annals of hematology
    70. THOMAS X; ANGLARET B; MARITAZ O; BAILLY M; FIERE D; ARCHIMBAUD E
      MODULATION OF CELL SENSITIVITY TO LYMPHOKINE-ACTIVATED KILLER (LAK) CYTOLYSIS - ROLE OF CYTOKINES AND DIFFERENTIATING AGENTS

      Experimental hematology
    71. ANGLARET B; THOMAS X; MOULLET I; BAILLY M; MARITAZ O; FIERE D; ARCHIMBAUD E
      DIFFERENTIAL ADHESIVENESS ON PURIFIED SUPPORTS BETWEEN BLOOD AND MARROW LEUKEMIC-CELLS HAVING SIMILAR PATTERN OF VLA ADHESION MOLECULES EXPRESSION

      Experimental hematology
    72. DEWITTE T; SUCIU S; BOOGAERTS M; LABAR B; ARCHIMBAUD E; AUL C; SELLESLAG D; FERRANT A; WEIJERMANS P; MANDELLI F; AMADORI S; MUUS P; DEMUYNCK H; DARDENNE M; WILLEMZE R; GRATWOHL A; APPERLEY J
      INTENSIVE ANTILEUKEMIC THERAPY INCLUDING STEM-CELL TRANSPLANTATION (SCT) FOR HIGH-RISK MDS AND AML FOLLOWING MDS (SAML) IN PATIENTS LESS-THAN-60 YEARS - A JOINT STUDY OF THE EORTC AND THE EBMT LEUKEMIA GROUPS

      Experimental hematology
    73. ESTEY E; THOMAS X; KEATING M; CHARRIN C; PIERCE S; ARCHIMBAUD E
      COMPARISON OF NEWLY-DIAGNOSED AML IN A FRENCH AND AN AMERICAN ACADEMIC HOSPITAL

      Blood
    74. MUUS P; ZITTOUN R; HAYAT M; MANDELLI F; WILLEMZE R; DEWITTE T; STRYCKMANS P; LABAR B; BERNEMAN Z; ARCHIMBAUD E; PETTI MC; JEHN U; SOLBU G; DARDENNE M; SUCIU S
      LONG-TERM SURVIVORS AFTER AML - FOLLOW-UP ON SURVIVAL AND LATE SIDE-EFFECTS OF THE AML5, AML6 AND AML8 STUDIES OF THE EORTC LEUKEMIA COOPERATIVE GROUP AND THE GIMEMA

      Blood
    75. MICHALLET M; BELHABRI A; MOULLET I; PHILIP I; TREMISI P; CHARRIN C; FIERE D; ARCHIMBAUD E
      COMPARISON BETWEEN PERIPHERAL-BLOOD STEM-CELLS (PBSC) MOBILIZED BY G-CSF (FILGRASTIM) AND INTERFERON-ALPHA (IF) AND PBSC HARVESTED AT DIAGNOSIS FOR AUTOLOGOUS TRANSPLANT IN CHRONIC MYELOID-LEUKEMIA (CML)

      Blood
    76. FENAUX P; CHASTANG C; SANZ M; ARCHIMBAUD E; DOMBRET H; LINK H; GUERCI A; FEGUEUX N; SANMIGUEL J; RAYON C; ZITTTOUN R; GARDIN C; MALOSIEL F; FEY M; CASTAIGNE S; CHOMIENNE C; DEGOS L
      EFFECT OF ATRA IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - VALIDATION OF SHORT-TERM EFFECT IN A LARGE MULTICENTER TRIAL (APL-93TRIAL) AND ASSESSMENT OF LONG-TERM BENEFIT (APL-91 TRIAL)

      Blood
    77. CASTAIGNE S; ARCHIMBAUD E; BORDESSOULE D; FENAUX P; TILLY H; DEREVEL T; SIMON M; JANVIER M; RENOUX M; GROSBOIS B; DUPRIEZ B; ZINI JM; TERTIAN G; LEGROS M; CHASTANG C; DEGOS L
      SEQUENTIAL INDUCTION OR DOUBLE INDUCTION CHEMOTHERAPY INCREASE DISEASE-FREE SURVIVAL COMPARED TO 3-CHEMOTHERAPY IN LESS-THAN 50 YEARS ADULTS WITH ACUTE MYELOID-LEUKEMIA (AML)(7)

      Blood
    78. ARCHIMBAUD E; OTTMANN O; YIN JAL; LECHNER K; DOMBRET H; SANZ MA; HERRMANN F; GRUSS H; FENAUX P; GANSER A; HEIL G; KANZ L; BRUGGER W; SIMS T; OLSEN K; HOELZER D
      A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY USING PEG-RHUMGDF AS AN ADJUNCT TO CHEMOTHERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) - EARLY RESULTS

      Blood
    79. DEWITTE; SUCIU S; BOOGAERTS M; LABAR B; ARCHIMBAUD E; AUL C; SELLESLAG D; FERRANT A; WEIJERMANS P; MANDELLI F; AMADORI S; JEHN U; MUUS P; DEMUYNCK H; DARDENNE M; WILLEMZE R; GRATWOHL A; APPERLEY J
      THE INFLUENCE OF CYTOGENETIC ABNORMALITIES ON TREATMENT OUTCOME AFTERINTENSIVE ANTILEUKEMIC THERAPY FOR PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS

      Blood
    80. MATTIJSSEN V; DEWITTE; SUCIU S; BOOGAERTS M; LABAR B; ARCHIMBAUD E; AUL C; SELLESLAG D; FERRANT A; WEIJERMANS P; MANDELLI F; AMADORI S; JEHN U; MUUS P; DEMUYNCK H; DARDENNE M; WILLEMZE R; GRATWOHL A; APPERLEY J
      THE PROGNOSTIC IMPACT OF THE PRESENCE OF AN HLA-IDENTICAL DONOR ON PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS TREATED WITH AN INTENSIVE ANTILEUKEMIC REGIMEN

      Blood
    81. ARCHIMBAUD E; PHILIP I; COIFFIER B; MICHALLET M; SALLES G; SEBBAN C; ROUBI N; LOPEZ F; BESSUEILLE L; MAZARS P; JUTTNER C; ATKINSON K; PHILIP T
      CD34(-) PERIPHERAL-BLOOD STEM-CELLS (PBSC) TRANSPLANTATION AFTER HIGH-DOSE THERAPY FOR PATIENTS WITH MULTIPLE MYUELOMA()THY1(+)LIN()

      Blood
    82. MICHALLET M; ARCHIMBAUD E; BANDINI G; ROWLINGS PA; DEEG HJ; GAHRTON G; MONTSERRAT E; ROZMAN C; GRATWOHL A; GALE RP
      HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION IN YOUNGER PATIENTSWITH CHRONIC LYMPHOCYTIC-LEUKEMIA

      Annals of internal medicine
    83. THOMAS X; VILA L; CAMPOS L; SABIDO O; ARCHIMBAUD E
      EXPRESSION OF N-CAM (CD56) ON ACUTE-LEUKEMIA CELLS - RELATIONSHIP WITH DISEASE CHARACTERISTICS AND OUTCOME

      Leukemia & lymphoma
    84. FENAUX P; CHASTANG C; CHOMIENNE C; CASTAIGNE S; SANZ M; LINK H; LOWENBERG B; FEY M; ARCHIMBAUD E; DEGOS L
      TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) BY ALL TRANSRETINOIC ACID (ATRA) COMBINED WITH CHEMOTHERAPY - THE EUROPEAN EXPERIENCE

      Leukemia & lymphoma
    85. THOMAS X; DANAILA C; BACH QK; DUFOUR P; CHRISTIAN B; CORRONT B; BOSLY A; BASTION Y; GRATECOS N; LEBLAY R; SEBBAN C; ARCHIMBAUD E; FIERE D
      SEQUENTIAL INDUCTION CHEMOTHERAPY WITH VINCRISTINE, DAUNORUBICIN, CYCLOPHOSPHAMIDE, AND PREDNISONE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Annals of hematology
    86. PHILIT F; WIESENDANGER T; ARCHIMBAUD E; MORNEX JF; BRUNE J; CORDIER JF
      POSTTRANSPLANT OBSTRUCTIVE LUNG-DISEASE (BROCHIOLITIS OBLITERANS) - ACLINICAL COMPARATIVE-STUDY OF BONE-MARROW AND LUNG-TRANSPLANT PATIENTS

      The European respiratory journal
    87. JOURDAN E; MARANINCHI D; REIFFERS J; ARCHIMBAUD E; MICHALLET M; HAROUSSEAU JL; IFRAH N; RIO B; GUYOTAT D; GUILHOT F; ATTAL M; LEBLOND V; DAURIAC C; LEGROS M; PICO JL; MARIT G; BLAISE D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION REMAINS AN EFFICIENT CONSOLIDATION FOR ADULTS WITH ACUTE MYELOID-LEUKEMIA EVEN WHEN PERFORMED VERY SOON AFTER DIAGNOSIS (LESS-THAN-100 DAYS)

      Leukemia
    88. THOMAS X; ARCHIMBAUD E; CHARRIN C; MAGAUD JP; FIERE D
      CD34 EXPRESSION IS ASSOCIATED WITH MAJOR ADVERSE PROGNOSTIC FACTORS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia
    89. ARCHIMBAUD E; THOMAS X; LEBLOND V; MICHALLET M; FENAUX P; CORDONNIER C; DREYFUS F; TROUSSARD X; JAUBERT J; TRAVADE P; TRONCY J; ASSOULINE D; FIERE D
      TIMED SEQUENTIAL CHEMOTHERAPY FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA - LONG-TERM FOLLOW-UP OF THE ETOPOSIDE, MITOXANTRONE, AND CYTARABINE-86 TRIAL

      Journal of clinical oncology
    90. ASSOULINE D; NEGRIER C; COQUARD I; ARCHIMBAUD E; FIERE D; BRET M; BODNAR D
      SUCCESSFUL SYSTEMIC THROMBOLYSIS OF HEPATIC VEIN-THROMBOSIS IN A PATIENT WITH PROMYELOCYTIC LEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID

      American journal of hematology
    91. ANGLARET B; THIEBAUT A; THOMAS X; MICHALLET M; FIERE D; ARCHIMBAUD E
      EFFECT OF CONTINUOUS INTRAVENOUS-INFUSION OF PENTOXIFYLLINE ON REGIMEN RELATED TOXICITY IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Experimental hematology
    92. THOMAS X; CAMPOS L; ANGLARET B; SABIDO O; FIERE D; ARCHIMBAUD E
      MODIFICATIONS IN THE EXPRESSION OF ADHESION MOLECULES ON ACUTE PROMYELOCYTIC LEUKEMIA (APL) CELLS WITH IN-VITRO DIFFERENTIATION

      Experimental hematology
    93. ARCHIMBAUD E; MICHALLET M; PHILIP I; SEBBAN C; DANAILA C; FIERE D
      G-CSF (FILGRASTIM) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANT IN CHRONIC MYELOID-LEUKEMIA

      Experimental hematology
    94. VILA L; THOMAS X; CAMPOS L; SABIDO O; ARCHIMBAUD E
      EXPRESSION OF VLA MOLECULES ON ACUTE-LEUKEMIA CELLS - RELATIONSHIP WITH DISEASE CHARACTERISTICS

      Experimental hematology
    95. PIGNEUX A; DEVERGIE A; POCHITALOFF M; RIO B; ARCHIMBAUD E; CAHN JY; LEBLOND V; MICHALLET M; JOUET JP; GUILHOT F; GLUCKMAN E; REIFFERS J
      RECOMBINANT ALPHA-INTERFERON AS TREATMENT FOR CHRONIC MYELOGENOUS LEUKEMIA IN RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE SOCIETE-FRANCAISE-LE-GREFFE-DE-MOELLE

      Bone marrow transplantation
    96. THOMAS X; ARCHIMBAUD E
      INFUSIONAL CYTOSINE-ARABINOSIDE ADMINISTR ATION FOR THE TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA

      Bulletin du cancer
    97. ARCHIMBAUD E; CHARRIN C; RIMOKH R; CAMPOS L; THOMAS X; MAGAUD JP; FIERE D
      ADULT ACUTE NON LYMPHOCYTIC-LEUKEMIA (ANLL) WITH CHROMOSOME 11Q23 BREAKPOINT - A COMPARISON WITH ANLL WITH NORMAL KARYOTYPE

      Blood
    98. BOOGAERTS MA; DEMUYNCK H; DEWITTE T; SUCIU S; LABAR B; ARCHIMBAUD E; RUNDE V; SELLESLAG D; ZITTOUN R; LELIE JVD; MUUS P; DARDENNE M; WILLEMZE R; GRATWOHL A; APPERLEY J
      REPOPULATION AFTER AUTOLOGOUS BONE-MARROW VERSUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN YOUNGER PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROMES IN COMPLETE REMISSION AFTER INTENSIFIED INDUCTION THERAPY - A JOINT EORTC EBMT STUDY/

      Blood
    99. THOMAS X; BELHABRI A; TREILLERITOUET D; FIERE D; ARCHIMBAUD E
      ACUTE PROMYELOCYTIC LEUKEMIA (APL) - THERAPY RESULTS AND PROGNOSTIC FACTORS OVER A 23-YEAR PERIOD

      Blood
    100. HAROUSSEAU JL; FACON T; MALOISEL F; DABOUZHARROUCHE F; WITZ F; GUILHOT F; ARCHIMBAUD E; DESABLENS B; ABGRALL JF; LINASSIER C; GROSBOIS B; BANCILLON A; BADRI N; BATAILLE R
      G-CSF INSTEAD OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER HIGH-DOSEMELPHALAN AS FRONT-LINE THERAPY IN MULTIPLE-MYELOMA

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 19:26:36